
Helius Medical Technologies continues its blockchain-focused expansion with a significant investment in Solana, reflecting a growing trend of corporate adoption of alternative digital assets.
Helius Medical Technologies has acquired 760,190 Solana (SOL) tokens as part of its broader treasury strategy. This acquisition follows a $500 million funding round led by Pantera Capital to establish a Solana-focused treasury company. Helius is among the first publicly traded companies to emphasize Solana in its corporate reserves.